650-263-7636   contact@endothelix.com             YouTube                                                                       

Guidelines for Endothelial Testing

Does Ubiquinol Supplementation Improve Endothelial Dysfunction, Dementia, and HFpEF?

Antioxidants (Basel) 2021 Jan 20;10(2):E143.

Ubiquinol Supplementation Improves Gender-Dependent Cerebral Vasoreactivity and Ameliorates Chronic Inflammation and Endothelial Dysfunction in Patients with Mild Cognitive Impairment

Sonia García-Carpintero 1 2Javier Domínguez-Bértalo 3Cristina Pedrero-Prieto 1 2Javier Frontiñán-Rubio 1 2Mariano Amo-Salas 4Mario Durán-Prado 1 2Eloy García-Pérez 5Julia Vaamonde 1 5Francisco J Alcain 1 2

Affiliations collapse

Affiliations

·     1 Department of Medical Sciences, Faculty of Medicine, University of Castilla-La Mancha, 13071 Ciudad Real, Spain.

·     2 Oxidative Stress and Neurodegeneration Group, Regional Centre for Biomedical Research, University of Castilla-La Mancha, 13071 Ciudad Real, Spain.

·     3 Neurology Department, Virgen de Altagracia Hospital-Manzanares, SESCAM, 13002 Manzanares, Spain.

·     4 Department of Mathematics, Faculty of Medicine, University of Castilla-La Mancha, 13071 Ciudad Real, Spain.

·     5 Neurology Department, General University Hospital-Ciudad Real, SESCAM, 13005 Ciudad Real, Spain.

 

Abstract

Ubiquinol can protect endothelial cells from multiple mechanisms that cause endothelial damage and vascular dysfunction, thus contributing to dementia. A total of 69 participants diagnosed with mild cognitive impairment (MCI) received either 200 mg/day ubiquinol (Ub) or placebo for 1 year. Cognitive assessment of patients was performed at baseline and after 1 year of follow-up. Patients’ cerebral vasoreactivity was examined using transcranial Doppler sonography, and levels of Ub and lipopolysaccharide (LPS) in plasma samples were quantified. Cell viability and necrotic cell death were determined using the microvascular endothelial cell line bEnd3. Coenzyme Q10 (CoQ) levels increased in patients supplemented for 1 year with ubiquinol versus baseline and the placebo group, although higher levels were observed in male patients. The higher cCoQ concentration in male patients improved cerebral vasoreactivity CRV and reduced inflammation, although the effect of Ub supplementation on neurological improvement was negligible in this study. Furthermore, plasma from Ub-supplemented patients improved the viability of endothelial cells, although only in T2DM and hypertensive patients. This suggests that ubiquinol supplementation could be recommended to reach a concentration of 5 μg/mL in plasma in MCI patients as a complement to conventional treatment.

Keywords: LPS; breath holding index; coenzyme Q10; endothelial necrosis; mild cognitive impairment.

 

Full-Text

 

Related Article:

 

BMC Cardiovasc Disord 2018 Apr 2;18(1):57.

Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose

Janet D Pierce 1 2Diane E Mahoney 1John B Hiebert 1Amanda R Thimmesch 3Francisco J Diaz 4Carol Smith 1Qiuhua Shen 1Dinesh Pal Mudaranthakam 4Richard L Clancy 2

·     University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.

Full-Text

 

 

Scientific Updates

Sponsored by Endothelix Inc.

View Archive

LATEST SCIENTIFIC UPDATES